Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Boundless Bio, Inc. - Common Stock
(NQ:
BOLD
)
1.200
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 31, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
100,792
Open
1.230
Bid (Size)
1.180 (1,200)
Ask (Size)
1.200 (200)
Prev. Close
1.200
Today's Range
1.150 - 1.240
52wk Range
1.000 - 3.120
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Boundless Bio to Participate in the Piper Sandler 37th Annual Healthcare Conference
November 24, 2025
From
Boundless Bio, Inc.
Via
GlobeNewswire
Boundless Bio Reports Third Quarter 2025 Financial Results and Business Highlights
November 05, 2025
From
Boundless Bio, Inc.
Via
GlobeNewswire
Performance
YTD
-56.0%
-56.0%
1 Month
+10.1%
+10.1%
3 Month
-2.4%
-2.4%
6 Month
+13.2%
+13.2%
1 Year
-55.4%
-55.4%
More News
Read More
Boundless Bio Announces Upcoming Presentation at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
October 13, 2025
From
Boundless Bio, Inc.
Via
GlobeNewswire
BOLD Stock Earnings: Boundless Bio Reported Results for Q1 2024
↗
May 13, 2024
Via
InvestorPlace
Boundless Bio (BOLD) Q2 R&D Drops 17%
↗
August 05, 2025
Via
The Motley Fool
Boundless Bio Reports Second Quarter 2025 Financial Results and Business Highlights
August 05, 2025
From
Boundless Bio, Inc.
Via
GlobeNewswire
Boundless Bio to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference
June 05, 2025
From
Boundless Bio, Inc.
Via
GlobeNewswire
Boundless Bio Announces Portfolio Prioritization and Runway Extension
May 23, 2025
From
Boundless Bio, Inc.
Via
GlobeNewswire
Boundless Bio Reports First Quarter 2025 Financial Results and Business Highlights
May 09, 2025
From
Boundless Bio, Inc.
Via
GlobeNewswire
Boundless Bio to Participate in the Needham Virtual Healthcare Conference
April 03, 2025
From
Boundless Bio, Inc.
Via
GlobeNewswire
Boundless Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights
March 27, 2025
From
Boundless Bio, Inc.
Via
GlobeNewswire
Boundless Bio to Participate in the Leerink Global Healthcare Conference
February 26, 2025
From
Boundless Bio, Inc.
Via
GlobeNewswire
Boundless Bio Appoints Robert Doebele, M.D., Ph.D., as Chief Medical Officer
February 03, 2025
From
Boundless Bio, Inc.
Via
GlobeNewswire
Boundless Bio Announces Pipeline and Leadership Updates
December 12, 2024
From
Boundless Bio, Inc.
Via
GlobeNewswire
Boundless Bio to Participate in the Piper Sandler Healthcare Conference
November 25, 2024
From
Boundless Bio, Inc.
Via
GlobeNewswire
Boundless Bio Reports Third Quarter 2024 Financial Results and Business Highlights
November 07, 2024
From
Boundless Bio, Inc.
Via
GlobeNewswire
Boundless Bio to Participate in the 2024 Guggenheim Global Healthcare Conference
November 05, 2024
From
Boundless Bio, Inc.
Via
GlobeNewswire
Boundless Bio Announces Departure of Chief Financial Officer
October 14, 2024
From
Boundless Bio, Inc.
Via
GlobeNewswire
Boundless Bio to Participate in the 2024 Cantor Global Healthcare Conference
September 11, 2024
From
Boundless Bio, Inc.
Via
GlobeNewswire
BOLD Stock Earnings: Boundless Bio Beats EPS for Q2 2024
↗
August 12, 2024
Via
InvestorPlace
Boundless Bio Provides Business Updates Focused on Key Value Drivers and Reports Second Quarter 2024 Financial Results
August 12, 2024
From
Boundless Bio, Inc.
Via
GlobeNewswire
Boundless Bio to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
June 05, 2024
From
Boundless Bio
Via
Business Wire
Boundless Bio Reports First Quarter 2024 Financial Results and Corporate Highlights
May 13, 2024
From
Boundless Bio
Via
Business Wire
Boundless Bio to Present at the Citizens JMP Life Sciences Conference 2024
May 06, 2024
From
Boundless Bio
Via
Business Wire
Boundless Bio Announces First Patient Dosed in First-in-Human Phase 1/2 Clinical Trial of BBI-825 in Cancer Patients with Resistance Gene Amplifications
April 11, 2024
From
Boundless Bio
Via
Business Wire
Frequently Asked Questions
Is Boundless Bio, Inc. - Common Stock publicly traded?
Yes, Boundless Bio, Inc. - Common Stock is publicly traded.
What exchange does Boundless Bio, Inc. - Common Stock trade on?
Boundless Bio, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Boundless Bio, Inc. - Common Stock?
The ticker symbol for Boundless Bio, Inc. - Common Stock is BOLD on the Nasdaq Stock Market
What is the current price of Boundless Bio, Inc. - Common Stock?
The current price of Boundless Bio, Inc. - Common Stock is 1.200
When was Boundless Bio, Inc. - Common Stock last traded?
The last trade of Boundless Bio, Inc. - Common Stock was at 12/31/25 04:00 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.